基因传递系统
Y.-Z.Duetal./InternationalJournalofPharmaceutics391 (2010) 260–266261
charge(Huetal.,2006b),allofwhichmakeitasapromisinggenevectorcandidate.
Thereweredemonstratedthatthegenetransfectionef ciencieshadrelationshipwiththeN/Pratio,size,stability,abilityofcellularuptakeofcomplexes,andthedissociationrateofDNAfromcom-plexesafterendocytosis(Weteringetal.,1997;Dokkaetal.,2000;Prabhaetal.,2002).Amongthose,sizeandstabilityofcomplexesarethetwomajorparameterstoobtainef cienttransfection.Thesizeofchitosannanoparticlesdictateditpermeabilizingonthecellmembrane(Huetal.,2006a)andthecomplexeswithsmallersizehadadvantagesinenteringthecellsthroughendocytosis,thereforeincreasingthetransfectionrate(Mansourietal.,2004).Itwasfoundthatthenanoparticleswithdiameter70±2nmexhibited27-foldhighertransfectionef ciencyinCSO-7celllinethanthatwithbig-gerdiameter(202±9nm)(Prabhaetal.,2002).Thebindingaf nityofpolycationwithDNAinresponsetotheadditionofsaltandpHchangewasdeterminedbyethidiumbromidedisplacementassay,whichwasaconventionalwayofmonitoringtheinteractionofpolyelectrolyte.Highbindingaf nityleadedtoDNAcondensation,thentohighstabilityandultimatelytohightransfectionef ciency(Gealletal.,1999).
Theaimofpresentstudyistogaininsightintoformula-tionparameterssuchasionicstrength,pH,N/Pratio(nitrogen/phosphateratio)andthepropertiesofCSO-SA(molecularweightofCSO-SA,aminosubstitutiondegree,pKa)whichhaveimpactonthecomplexationandstabilityofcomplexes.Dataobtainedinpresentworktendstoprovidetheguidelineindesignofcom-plexeswithhighstabilityandtransfectionef ciency,whichareparticularlyimportanttobeagenedeliverysystemusingmodi edchitosan.
2.Materialsandmethods2.1.Materials
Chitosan(MW:450.0kDa,DeacetylationDegree:95%)wasobtainedfromYuhuanMarineBiochemistryCo.,Ltd.(Zhejiang,China).ChitosanasewaspurchasedfromChemicalIndustriesCo.,Ltd.(Japan).StearicacidwaspurchasedfromShanghaiChemi-calReagentCo.,Ltd.(China).1-Ethyl-3-(3-dimethylaminepropyl)carbodiimide(EDC),2,4,6-trinitrobenzenesulfonicacid(TNBS)andethidiumbromide(EtBr)waspurchasedfromSigma(St.Louis,USA).Sodiumhydroxide(NaOH)andhydrochloride(HCl)werepurchasedfromHangzhouchemicalreagentCo.,Ltd.(Zhe-jiang,China).FishspermDNAwaspurchasedfromSangonBiologicalEngineeringTechnology&ServiceCo.,Ltd.(ShanghaiChina).Otherreagentsusedintheexperimentwereanalyticalgrade.
2.2.SynthesisofCSO-SA
Chitosanoligosaccharide(CSO)waspreparedbyenzymatichydrolysisofchitosan(MW:450kDa,deaceylationdegree:95%)(Huetal.,2006b).Thehydrolysisprocesswasmonitoredbygelpermeationchromatography(GPC)andterminatedwhendesirablemolecularweightwasobtained.Thereactantwasfurtherpuri edbyultra- ltrationtoobtaintheproductwithnarrowmolecularweightdistribution.Stearicacid(SA)wasthencoupledwithchi-tosanoligosaccharideviareactionofcarboxylgroupsofSAwithprimaryaminogroupsofCSOcatalyzedbyEDC.Brie y,CSO(1g)wasdissolvedin200mLsuper-puri edwater,andSA(theamountofSAwasvariedwiththedifferenttypeofCSO-SA)andEDCwasdis-solvedin100mLethanol.ThecarboxylgroupsofSAwereactivatedbyEDC,whichwas10-foldmolarexcessoverSA.TheactivatedSAwasaddedintoCSOsolutionandallowedtoreactwith400rpm
for24hat60 Cwaterbath.The nalreactantwasdialyzedbyemployingdialysismembrane(MW:3kDa,SpectrumLaboratories,LagunaHills,CA)againstsuper-puri edwaterfor72hinordertoremovetheby-productcompletely.Thedialyzedproductwasthenlyophilized.
2.3.Determinationofcriticalmicelleconcentration(CMC)
Pyrene uorescencemethodwasemployedforCMCdetermina-tionofCSO-SA.Firstofall,pyrenestocksolutionwaspreparedbydissolving6mgpyrenein50mLacetone.Thepyrenestocksolutionwasfurtherdilutedwithacetonefor100times.0.5mLaliquotsofpyrenesolutionwithconcentrationof0.0012mg/mLweretrans-ferredpreciselyintotesttubesandthesolventwasevaporatedindarkat50 C.5mLpolymersolutionwithconcentrationrange1.25mg/mLto10 4mg/mLwasaddedtotesttubesandthe nalconcentrationofpyreneinmixtureswascontrolledat6×10 7M.Theemissionspectraofmixturewasmeasuredbyusing uorom-eter(F-2500,HITACHICo.,Japan).Theexcitationwavelengthwas337nm.Theslitopeningsofexcitationandemissionweresetat10nmand2.5nm,respectively.
2.4.PreparationofCSO-SA/DNAcomplexes
Brie y,commercial shspermDNA(5mg/mL)wasdilutedwithsuper-puri edwatertogiveaconcentrationof1mg/mL.TheCSO-SA/DNAchargeratiowasexpressedasmolarratiooftheprimaryaminogroupsofCSO-SAtothoseofthephosphategroupsofDNA(N/Pratio).ThecomplexeswithdifferentN/Pratiowerethenpre-paredbydropwiseadditionofDNAsolutionintoCSO-SAsolutionwithconcentrationof1mg/mLatambienttemperature,andfol-lowinggentlemagneticstirringfor5min.2.5.Sizeandzetapotentialdetermination
ThesizesandzetapotentialsofCSO-SAmicellesandCSO-SA/DNAcomplexesweremeasuredbyDynamicLightScattering(Zetasizer3000HSA,MalvernInstrumentsLtd.,UK).Sizeswerepre-sentedinthissectionisZ-averagediametervalue.Eachsampledeterminationwasdoneintriplicate.2.6.TNBSassay
TNBSassaywasemployedtodeterminequantitativelythesub-stitutiondegree(SD)ofaminogroupsinCSO-SA.10mgofCSO-SAwasdissolvedin10mLofsuper-puri edwater.Then,300 Lof1mg/mLCSO-SAsolutionwasmixedwith2mLofsodiumhydrogencarbonate(4%,w/v)and2mLofTNBSsolution(0.1%,w/v),whichwasincubatedinwaterbathfor2hat37 C.TheUVabsorbanceat344nmoftheproductagainstablankpreparedwithsuper-puri edwater,sodiumhydrogencarbonatesolutionandTNBSsolutionundersameprocesswasdeterminedbyUVspectropho-tometer(TU-1800PC,BeijingPurkinjeGeneralInstrumentCo.,Ltd.,China)after2mLofhydrochloricacidwasadded.SDofCSO-SAwascalculatedfromtheUVabsorbanceofCSO-SAandunmodi edCSO.
2.7.Potentiometricmeasurement
CSO-SA(10mg)wasdissolvedin20mLsuper-puri edwatertoprepareCSO-SAsolutionwithconcentrationof0.5mg/mL.EqualaliquotsofNaOHsolution(0.01M)wastitratedpreciselyintoCSO-SAsolutionbyusingpipettewithstirringatrateof400rpmduringtheaddition.pHwasmeasuredbypHmeter(320pHmeter,MetterToledo,USA)aftertitrationequilibriumwasachieved.
Gene delivery system 7页 1财富值 Chitosan Nanoparticles A... 8页 1财富值 Non-viral targeted deliv... 暂无评价 4页 2.00元 #Chitosan nanoparticles ....
9页 1财富值 Enhancement of Microbubb... 8页 2财富值 Gene delivery system 7页 1财富值 Drug and Gene Delivery 暂无评价 41页 5财富值...
11页 免费 Delivery of Information 11页 免费 information system 6页 5财富值 Project Delivery System 46页 2财富值 Gene delivery system 7页 1财富值...
基因导入系统(gene delivery system)是 基因治疗的核心技术,可分为病毒载体 系统和非病毒载体系统。 42 ? ? ? 1.病毒载体系统 用于基因治疗的病毒载体应具备以下...
GDS-80 Gene Delivery System 子弹制备流程—Helios系统 DNA与金粉共沉淀 (Spermidine/CaCl2) 悬浮在酒精中, DNA/金粉流入 塑料管中 旋转使DNA/金粉均匀分布在...
In addition, we briefly illustrate gene delivery system used in miRNA therapy and obstacles at present. Key words: MiRNA; Cancer; Gene therapy Chinese ...
共 113 页第 25 页 2008-1-28 15:21:05 PM Gene Gene expression system Gene vector system Gene delivery system 共 113 页第 26 页 2008-1-28 15:...
高表面活性 → 交联或吸附性强 Drug / Gene Delivery System 药物/基因转运系统 药物 基因转运系统 纳米粒 吸附药物/质粒 吸附药物 质粒DNA 质粒 纳米粒-药物 ...
In t his article, t he structure f orm at of cat ionic liposomes w as int roduced, tw o types of liposomes mediated gene delivery system w ith ...
transfer is reviewed in this paper, the basic principle and the latest progress and the development trend of polymeric gene delivery system were discussed....
热门文档